(S)-crizotinib
99%
- Product Code: 99236
CAS:
1374356-45-2
| Molecular Weight: | 450.34 g./mol | Molecular Formula: | C₂₁H₂₂Cl₂FN₅O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22126092 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
(S)-crizotinib is primarily used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It works by inhibiting the activity of the ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) proteins, which are involved in the growth and spread of cancer cells. By blocking these proteins, (S)-crizotinib helps to slow down or stop the progression of the disease. It is often prescribed when the cancer has metastasized or is in advanced stages. The drug is typically administered orally in the form of tablets or capsules, and its use is closely monitored by healthcare professionals to manage potential side effects and ensure effectiveness.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | white to yellow solid |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿8,000.00 |
+
-
|
| 0.010 | 10-20 days | ฿12,000.00 |
+
-
|
(S)-crizotinib
(S)-crizotinib is primarily used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It works by inhibiting the activity of the ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) proteins, which are involved in the growth and spread of cancer cells. By blocking these proteins, (S)-crizotinib helps to slow down or stop the progression of the disease. It is often prescribed when the cancer has metastasized or is in advanced stages. The drug is typically administered orally in the form of tablets or capsules, and its use is closely monitored by healthcare professionals to manage potential side effects and ensure effectiveness.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :